Correlation Between Morgan Stanley and OncoSec Medical

Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and OncoSec Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and OncoSec Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morgan Stanley Direct and OncoSec Medical, you can compare the effects of market volatilities on Morgan Stanley and OncoSec Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of OncoSec Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and OncoSec Medical.

Diversification Opportunities for Morgan Stanley and OncoSec Medical

-0.84

Correlation Coefficient

Morgan Stanley  OncoSec Medical

Pay attention - limited upside

The 3 months correlation between Morgan and OncoSec is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and OncoSec Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoSec Medical and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with OncoSec Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoSec Medical has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and OncoSec Medical go up and down completely randomly.

Pair Corralation between Morgan Stanley and OncoSec Medical

Given the investment horizon of 90 days Morgan Stanley Direct is expected to generate 0.11 times more return on investment than OncoSec Medical. However, Morgan Stanley Direct is 9.0 times less risky than OncoSec Medical. It trades about 0.04 of its potential returns per unit of risk. OncoSec Medical is currently generating about -0.11 per unit of risk. If you would invest  1,862  in Morgan Stanley Direct on October 3, 2024 and sell it today you would earn a total of  221.00  from holding Morgan Stanley Direct or generate 11.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	56.12%
Values	Daily Returns

Morgan Stanley Direct  vs.  OncoSec Medical

Morgan Stanley Direct

Risk-Adjusted Performance

8 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Direct are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile fundamental indicators, Morgan Stanley may actually be approaching a critical reversion point that can send shares even higher in February 2025.

OncoSec Medical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days OncoSec Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, OncoSec Medical is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Morgan Stanley and OncoSec Medical

The main advantage of trading using opposite Morgan Stanley and OncoSec Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, OncoSec Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoSec Medical will offset losses from the drop in OncoSec Medical's long position.

The idea behind Morgan Stanley Direct and OncoSec Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.